Development and Validation of an RP‐HPLC Method for Organic Impurity Profiling in Baclofen Utilizing Robustness Through a Quality‐by‐Design (QbD) Approach: A Comprehensive Forced Degradation Assessment

Ähnliche Einträge

• QbD‐Based HPLC Method Development for Trace‐Level Detection of Genotoxic 3‐Methylbenzyl Chloride in Meclizine HCl Formulations
  von: Naga Kranthi Kumar Chintalapudi, et al.
  Veröffentlicht: (2025)
• Development, evaluation of critical method variables and stability assessment using a Box–Behnken design for the determination of organic impurities in a pharmaceutical dosage form of a centrally acting muscle relaxant drug chlorzoxazone
  von: Santhosh Kumar Ettaboina, et al.
  Veröffentlicht: (2024)
• Box–Behnken Design–Based Development and Validation of RP‐HPLC Method for Determination of Related Substances in Nitrofurantoin Formulations
  von: Prasanth Katakam, et al.
  Veröffentlicht: (2025)
• Stability‐Indicating RP‐HPLC Method Development and Validation for the Quantification of Ketorolac Tromethamine‐Related Impurities in Tablets Solid Oral Dosage Forms
  von: Prasanna Kumar Lankalapalli, et al.
  Veröffentlicht: (2025)
• Quality by Design Based Chromatography Technique Development and Validation for the Medicine Venetoclax (for Chronic Leukemia), in the Context of Impurities Including Degradation Products
  von: Rajeshwari Dandabattina, et al.
  Veröffentlicht: (2025)